- Home
- SBFM vs GIPR Comparison
SBFM vs GIPR Comparison
Compare SBFM & GIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- GIPR
- Stock Information
- Founded
- SBFM 2006
- GIPR 2015
- Country
- SBFM United States
- GIPR United States
- Employees
- SBFM N/A
- GIPR N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- GIPR Real Estate Investment Trusts
- Sector
- SBFM Health Care
- GIPR Real Estate
- Exchange
- SBFM Nasdaq
- GIPR Nasdaq
- Market Cap
- SBFM 7.7M
- GIPR 7.7M
- IPO Year
- SBFM N/A
- GIPR 2021
- Fundamental
- Price
- SBFM $1.54
- GIPR $1.57
- Analyst Decision
- SBFM Strong Buy
- GIPR
- Analyst Count
- SBFM 1
- GIPR 0
- Target Price
- SBFM $15.00
- GIPR N/A
- AVG Volume (30 Days)
- SBFM 183.7K
- GIPR 16.9K
- Earning Date
- SBFM 08-15-2025
- GIPR 08-14-2025
- Dividend Yield
- SBFM N/A
- GIPR N/A
- EPS Growth
- SBFM N/A
- GIPR N/A
- EPS
- SBFM N/A
- GIPR N/A
- Revenue
- SBFM $36,234,578.00
- GIPR $9,711,058.00
- Revenue This Year
- SBFM $192.48
- GIPR N/A
- Revenue Next Year
- SBFM N/A
- GIPR N/A
- P/E Ratio
- SBFM N/A
- GIPR N/A
- Revenue Growth
- SBFM 35.51
- GIPR 11.25
- 52 Week Low
- SBFM $1.17
- GIPR $1.33
- 52 Week High
- SBFM $7.60
- GIPR $4.15
- Technical
- Relative Strength Index (RSI)
- SBFM 57.58
- GIPR 53.76
- Support Level
- SBFM $1.42
- GIPR $1.46
- Resistance Level
- SBFM $1.75
- GIPR $1.55
- Average True Range (ATR)
- SBFM 0.12
- GIPR 0.06
- MACD
- SBFM 0.01
- GIPR 0.02
- Stochastic Oscillator
- SBFM 61.81
- GIPR 77.27
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About GIPR Generation Income Properties Inc.
Generation Income Properties Inc is an internally managed real estate investment company focused on acquiring and managing income-producing retail, office and industrial properties net leased to high-quality tenants in markets throughout the United States. Its key source of revenue is the rental income. The company holds properties in Alabama, Arizona, Colorado, the District of Columbia, Florida, Illinois, North Carolina and Virginia.